DIAGNOSTIC TESTS being developed by Yemi Adesokan and his company could let physicians quickly and cheaply pinpoint features of a patient's infection, such as whether it is resistant to certain antibiotics, and prescribe the most effective treatment. In 2009, as a postdoctoral researcher at Harvard, Adesokan cofounded a startup called Pathogenica with the goal of developing commercial applications of DNA-sequencing technologies. Adesokan, the CEO, expects to create a market for tests that use sequencing to detect the microbes behind infections.
展开▼
